Sign In
Buy ARCT
$7.60
-0.0500 (-0.654%)
At Close: Jun 03, 2026
3 Small-Cap Coronavirus Stocks That Could Skyrocket
11:04am, Sunday, 02'nd Aug 2020
There are many small biotechs developing experimental COVID-19 therapies and vaccine candidates. Arcturus' market cap now tops $1 billion. Arcturus announced in March that it was teaming up with Duk
Navigating The Pandemic And Beyond
04:43am, Sunday, 02'nd Aug 2020
We still expect the economy to remain on a recovery path but it will not be as quick as earlier assumed.
'Be Wary Of Cashing In': Stock Market Update For The Week Ahead
12:00am, Sunday, 02'nd Aug 2020
The Past Week, In A Nutshell
What Happened: Stocks closed the week practically unchanged after mixed reactions to a slew of blow-out earnings results.
Remember This: “...
SAN DIEGO, July 31, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development
Do Institutions Own Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares?
12:59pm, Friday, 31'st Jul 2020
A look at the shareholders of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) can tell us which group is most...
Glaxo and Sanofi Will Sell 100 Million Covid-19 Vaccine Doses to the U.S. for Less Than $10.50 Each
11:00am, Friday, 31'st Jul 2020
The deal appears to price the vaccine at less than $10.50 a dose.
Moderna Targeted By Chinese Hackers For Data Theft: Report
12:00am, Friday, 31'st Jul 2020
Moderna Inc (NASDAQ: MRNA), which commenced a late-stage trial of its mRNA vaccine, codenamed mRNA-1273, against SARS-CoV-2 earlier in the week, has been reportedly targeted...
Moderna board member resigns to prevent perception of conflict of interest in vaccine trial
08:39pm, Thursday, 30'th Jul 2020
Shares of Moderna Inc. undefined were down 0.2% in trading on Thursday after the market closed when it said a board member had resigned to avoid the...
Moderna Stock: How Best to Profit From This Pharmaceutical Stock
11:45am, Thursday, 30'th Jul 2020
Moderna stock has had one of the best times of any stock in 2020, but the future is growing more uncertain for the company as the COVID-19 vaccine continues to undergo trials.
August Outlook: Politics Likely To Be In Play As New Month Gets Started
12:00am, Thursday, 30'th Jul 2020
Some say never bring up politics. Looking ahead to August on Wall Street, though, it’s hard to avoid.
Entering the month, the big question is whether Congress and the White...
Stocks making the biggest moves in the premarket: Boeing, GE, GM, Spotify, Eastman Kodak & more
12:06pm, Wednesday, 29'th Jul 2020
The stocks making the biggest moves in premarket trading include Boeing, GE, GM, Spotify, Eastman Kodak, and more.
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
04:30am, Wednesday, 29'th Jul 2020
SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development
The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More
12:00am, Wednesday, 29'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 28)
Axonics Modulation Technologies Inc (NASDAQ: AXNX)
Capricor Therapeutics Inc (NASDAQ: CAPR)
Fulgent Genetics Inc...
Arcturus Therapeutics Announces Proposed Public Offering of Common Stock
08:01pm, Tuesday, 28'th Jul 2020
SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development
MRNA Stock Jumps 9%, Moderna Gets $472M for Vaccine Research
10:37am, Tuesday, 28'th Jul 2020
Moderna has got nearly $1B in support from the U.S. government so far to support the development of the COVID-19 vaccine, MRNA is up.
